**EXHIBIT 23.01****CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**We consent to the incorporation by reference in this Annual Report (Form 10-K) of MartekBiosciences Corporation of our report dated January 6, 2006, with respect to the consolidatedfinancial statements of Martek Biosciences Corporation, included in the 2005 Annual Report toShareholders of Martek Biosciences Corporation.Our audits also included the financial statement schedule of Martek Biosciences Corporation listedin Item 15(a)(2). This schedule is the responsibility of Martek Biosciences Corporation’smanagement. Our responsibility is to express an opinion based on our audits. In our opinion, as towhich the date is January 6, 2006, the financial statement schedule referred to above, whenconsidered in relation to the basic financial statements taken as a whole, present fairly in allmaterial respects the information set forth therein.We consent to the incorporation by reference in the following Registration Statements:(1) Registration Statement (Form S-3 No. 33-93580) of Martek Biosciences Corporation, (2) Registration Statement (Form S-3 No. 333-34460) of Martek Biosciences Corporation, (3) Registration Statement (Form S-3 No. 333-57176) of Martek Biosciences Corporation, (4) Registration Statement (Form S-3 No. 333-76750) of Martek Biosciences Corporation, (5) Registration Statement (Form S-3 No. 333-87934) of Martek Biosciences Corporation, (6) Registration Statement (Form S-3 No. 333-106953) of Martek Biosciences Corporation, (7) Registration Statement (Form S-3 No. 333-108825) of Martek Biosciences Corporation, (8) Registration Statement (Form S-3 No. 333-115706) of Martek Biosciences Corporation, (9) Registration Statement (Form S-8 No. 33-79222) pertaining to the Martek BiosciencesCorporation Stock Option Plan, Martek Biosciences Corporation Directors’ Stock Option Plan andMartek Biosciences Corporation 401(k) Retirement Savings Plan, (10) Registration Statement (Form S-8 No. 333-46949) pertaining to the Martek BiosciencesCorporation 1997 Employee Stock Option Plan, (11) Registration Statement (Form S-8 No. 333-27671) pertaining to the Martek BiosciencesCorporation 1997 Stock Option Plan, (12) Registration Statement (Form S-8 No. 333-84317) pertaining to the Martek BiosciencesCorporation 1997 Amended Stock Option Plan, (13) Registration Statement (Form S-8 No. 333-52298) pertaining to the Martek BiosciencesCorporation 1997 Amended Stock Option Plan, (14) Registration Statement (Form S-8 No. 333-74092) pertaining to the 2001 Stock Option Plan, (15) Registration Statement (Form S-8 No. 333-85856) pertaining to the 2002 Stock Incentive Plan, (16) Registration Statement (Form S-8 No. 333-87016) pertaining to the 2002 Stock Incentive Plan, (17) Registration Statement (Form S-8 No. 333-105555) pertaining to the 2002 Stock Incentive Plan, (18) Registration Statement (Form S-8 No. 333-117671) pertaining to the 2004 Stock Incentive Plan,and (19) Registration Statement (Form S-8 No. 333-125802) pertaining to the Company’s Amended andRestated 2004 Stock Incentive Planof our report dated January 6, 2006, with respect to the consolidated financial statements ofMartek Biosciences Corporation included herein, our report dated January 6, 2006, with respect toMartek Biosciences Corporation management’s assessment of the effectiveness of internal controlover financial reporting and the effectiveness of internal control over financial reporting ofMartek Biosciences Corporation, included herein, and our report included in the preceding paragraphwith respect to the financial statement schedule of Martek Biosciences Corporation included in thisAnnual Report (Form 10-K) of Martek Biosciences Corporation.                                                                    /s/ Ernst & Young LLP         McLean, Virginia